Evidence map›Paper›PMID 31451621›Full record

ArticleInfection and immunity2019

Interleukin-22 (IL-22) Binding Protein Constrains IL-22 Activity, Host Defense, and Oxidative Phosphorylation Genes during Pneumococcal Pneumonia.

Giraldina Trevejo-Nunez, Waleed Elsegeiny, Felix E Y Aggor, Jamie L Tweedle, Zoe Kaplan, Pranali Gandhi, Patricia Castillo, Annabel Ferguson, John F Alcorn, Kong Chen and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Disease tolerance: a protective mechanism of lung infections.Frontiers in cellular and infection microbiology · 2023
    Review
  10. Interleukin-22: a potential therapeutic target in atherosclerosis.Molecular medicine (Cambridge, Mass.) · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Giraldina Trevejo-NunezDivision of Infectious Diseases. University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA giraldina.trevejo@pitt.edu.
Waleed ElsegeinyUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-1170-4890
Felix E Y AggorDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Jamie L TweedleDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Zoe KaplanUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Pranali GandhiDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Patricia CastilloUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Annabel FergusonDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
John F AlcornUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kong ChenDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Jay K KollsUPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sarah L GaffenDivision of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
University of Pittsburgh · USChildren's Hospital of Pittsburgh · USTulane University · US

Funding

Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6M
Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
Influenza A Inhibits TH17 Host Defense Against Bacterial PneumoniaR01HL107380 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALCORN, JOHN F · 2012 to 2024
$5.4M
Th17 Cytokines and Lung ImmunityR37HL079142 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 2010 to 2017
$3.6M
Role of IL-22/IL-22RA2 during pneumococcal pneumoniaK01HL135476 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TREVEJO-NUNEZ, GIRALDINA · 2017 to 2021
$836k
Domain-specific role of IL-17RA in controlling Klebsiella pneumoniae lung infectionR03HL154231 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TREVEJO-NUNEZ, GIRALDINA · 2020 to 2021
$157k
NHLBI NIH HHS K01 HL135476NHLBI NIH HHS R01 HL107380NHLBI NIH HHS R03 HL154231NHLBI NIH HHS R35 HL139930NHLBI NIH HHS R37 HL079142NIAID NIH HHS T32 AI089443NIDCR NIH HHS R37 DE022550
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell LineDisease SusceptibilityEpithelial CellsGene Expression RegulationInterleukin-22InterleukinsLeukocyte Common AntigensLungMacrophagesMiceMice, KnockoutOxidation-ReductionPhosphorylationPneumonia, PneumococcalReceptors, InterleukinInterleukin-22interleukin-22 receptorInterleukinsLeukocyte Common AntigensPtprc protein, mouseReceptors, Interleukinhost defenseIL-22BPOXPHOS

Identifiers

PMID31451621
PMCPMC6803344
OpenAlexW2969998801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.